Chimeric Influenza-VLP used as vaccine platform for presentation of foreign antigens - Application to Malaria antigens

Project Information

FLU-MAL VLP

Grant agreement ID: 624939

Project closed

Start date 1 September 2014

End date 21 December 2016

Funded under

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 194 046,60

EU contribution € 194 046,60

Coordinated by

UNIVERSITE LYON 1 CLAUDE BERNARD
France